Buscar
Mostrando ítems 1-10 de 110
Doença periodontal e angina pectoris estável: um estudo caso-controle
(Universidade Federal do Rio Grande do NorteBRUFRNPrograma de Pós-Graduação em OdontologiaOdontologia Preventiva e Social; Periodontia e Prótese Dentária, 2009-04-20)
The search which it aim was to analyze the Periodontal Disease as a risk factor for the development of the Stable Angina Pectoris. For that, 120 patients (52 blokes and 68 wenches ), ages ranging from 40 to 65 years old, ...
Validation of the Short-Version of Rose Angina Questionnaire in Brazil
(ARQUIVOS BRASILEIROS CARDIOLOGIARIO DE JANEIRO, 2012)
Background: Stable angina pectoris is a serious condition with few epidemiological studies in Brazil. Objective: To validate the short-version of the Rose angina questionnaire in Brazilian Portuguese for its implementation ...
Sensitivity, specificity and predictive values of linear and nonlinear indices of heart rate variability in stable angina patients
(2012-10-31)
Background: Decreased heart rate variability (HRV) is related to higher morbidity and mortality. In this study we evaluated the linear and nonlinear indices of the HRV in stable angina patients submitted to coronary ...
Sensitivity, specificity and predictive values of linear and nonlinear indices of heart rate variability in stable angina patients
(2012-10-31)
Background: Decreased heart rate variability (HRV) is related to higher morbidity and mortality. In this study we evaluated the linear and nonlinear indices of the HRV in stable angina patients submitted to coronary ...
Additional and emerging drugs for standard therapy for patients with stable angina
(Universidade Federal de Minas GeraisBrasilMED - DEPARTAMENTO DE CLÍNICA MÉDICAUFMG, 2017-06)
Ranolazine for stable angina pectoris
(Wiley, 2017)
BACKGROUND: Stable angina pectoris is a chronic medical condition with significant impact on mortality and quality of life; it can be macrovascular or microvascular in origin. Ranolazine is a second-line anti-anginal drug ...
Nuevos enfoques farmacológicos en el manejo de la angina de pecho estable
ABSTRACT In recent years, new antianginal agents with novel mechanisms of action have been launched to the market, as a complement to the existing therapeutic arsenal. Even though the beta-blockers, calcium channel blockers ...